Stocks and Investing Stocks and Investing
Mon, December 14, 2020
Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020
Fri, December 4, 2020

Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $44 on, Dec 4th, 2020


Published on 2024-10-27 14:55:55 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $39 to $44 on, Dec 4th, 2020.

Mani has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mani


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $53 on, Monday, October 12th, 2020